Celldex Therapeutics, Inc. (CLDX) Executive Compensation
Celldex Therapeutics, Inc. (CLDX) is a publicly traded company on the Nasdaq, categorized under SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CLDX
CIK: 744218
Exchange: Nasdaq
SIC 2835: In Vitro & In Vivo Diagnostic Substances
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerEmily Rando
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-10-07 | — | SCHEDULE 13G/A Filing | 0000315066-26-002325 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | FORM 8-K | 0001104659-26-109465 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001907884-26-000013 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000080255-26-000537 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-091984 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001171843-26-005316 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-10 | FORM 8-K | 0001104659-26-083880 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001960596-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001838114-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001648010-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001718112-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001709024-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001709113-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001681854-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001214504-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001429931-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001429933-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001820278-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001707797-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001586785-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001529371-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001518575-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001198578-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001218815-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001131148-26-000002 | View SEC Doc Filr Page |